David Berman
Chief Tech/Sci/R&D Officer presso IMMUNOCORE HOLDINGS PLC
Patrimonio netto: - $ in data 31/03/2024
Profilo
David Berman is currently the Head of Research & Development at Immunocore Holdings Plc.
Prior to this, he was the Head of Immuno Oncology at Bristol Myers Squibb Co. from 2005 to 2015, the Head of Early Stage Oncology Program at MedImmune LLC from 2015 to 2017, and the Head of Immuno Oncology Franchise at AstraZeneca PLC from 2017 to 2018.
Berman received his undergraduate degree from Massachusetts Institute of Technology and his graduate and doctorate degrees from The University of Texas Southwestern Medical Center.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
IMMUNOCORE HOLDINGS PLC
-.--% | 28/02/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di David Berman
| Società | Posizione | Inizio |
|---|---|---|
| IMMUNOCORE HOLDINGS PLC | Chief Tech/Sci/R&D Officer | 01/01/2019 |
Precedenti posizioni note di David Berman
| Società | Posizione | Fine |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/2018 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01/01/2017 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2015 |
Formazione di David Berman
| Massachusetts Institute of Technology | Undergraduate Degree |
| The University of Texas Southwestern Medical Center | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| IMMUNOCORE HOLDINGS PLC | Health Technology |
| Aziende private | 1 |
|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
- Borsa valori
- Insiders
- David Berman
